Dissolving microneedles with a biphasic release of antibacterial agent and growth factor to promote wound healing. (6th April 2022)

• Record Type: Journal Article
• Authors: Chen, Yonghang; Yu, Weijiang; Qian, Xuedan; Li, Xinfang; Wang, Youxiang; Ji, Jian
• Is Part Of: Biomaterials science. Volume 10:Number 9(2022)
• Page Start: 2409
• Page End: 2416
• Publication Date: 2022-04-06
• Subjects: Biomedical materials -- Periodicals; 610.28
• DOI: 10.1039/d2bm00281g
• Languages: English
• ISSNs: 2047-4830

Abstract

Abstract : Dissolving microneedles achieved the biphasic release of ofloxacin and bFGF and were suitable for the physiological process of wound healing. Abstract : Infected wound healing is a complex and dynamic process affecting millions of people. Since wound healing contains multiple stages, it requires staged management to realize the early inhibition of infection and the subsequent promotion of wound healing. A key point is to design a biphasic release system with antibacterial agents and growth factors to promote wound regeneration. As a safe, efficient and painless transdermal drug delivery method, microneedles (MNs) have attracted widespread attention. Herein, we present dissolving MNs with the biphasic release of an antibacterial agent and a growth factor to promote wound healing. bFGF was first encapsulated in PLGA microspheres (bFGF@PLGA) and then co-loaded with free ofloxacin onto polyvinylpyrrolidone MNs. Owing to the fast dissolution of the substrate, ofloxacin was quickly released to rapidly inhibit infection, while the PLGA microspheres were left in the wound. Due to the slow degradation of PLGA, bFGF encapsulated in the PLGA microspheres was slowly released to further promote wound healing. In vivo studies demonstrated that the MNs with the biphasic release of antibacterial agent and growth factor exhibited a superior capability to promote wound healing. This biphasic release system combined with microneedles has a bright future in wound healing.